Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05667948

Molecular Analysis and Treatment Options of Thymic Malignancies

Sponsor: Shanghai Chest Hospital

View on ClinicalTrials.gov

Summary

Thymic malignancies are the most common tumors of the anterior mediastinum, though surgery and radiation often effectively treat thymic carcinomas, a minority continue to progress and eventually lead to death. Therefore, there is an unmet need for more effective therapies for thymic malignancies. Considering the role of molecular alterations has yet to be defined in the treatment of thymoma and thymic malignancies, there is an urgent recognition that molecular alterations in the thymic malignancies are important to predict response and survival for novel targeted therapies. In summary, identification of genetic alterations in thymic malignancies is increasingly essential to perform molecular diagnostics and individualized treatments. This project aims to create a registry of patients with thymic malignancies to further the characterization of molecular alterations and develop (novel) treatments based on the detection.

Official title: Molecular Landscape Analysis and Treatment Options for Thymic Epithelial Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2016-01-01

Completion Date

2026-12-31

Last Updated

2025-05-22

Healthy Volunteers

No

Interventions

DRUG

Chemotherapy

different treatments based on the molecular analysis

Locations (1)

Xiaomin Niu

Shanghai, Shanghai Municipality, China